Alibaba Health's Fiscal Full-Year 2026 Profit Rises; Dividend Declared

MT Newswires Live05-14

Alibaba Health Information Technology (HKG:0241) recorded a rise in attributable profit to 1.94 billion yuan in the year ended March 31, up from 1.43 billion yuan a year prior.

Earnings per share rose to 0.1195 yuan from 0.0888 yuan in the previous fiscal year, according to a Thursday Hong Kong bourse filing.

Revenue jumped to 34.26 billion yuan from 30.6 billion yuan in the year-ago period, thanks mainly to the development of the pharmaceutical direct sales business, as well as healthcare and digital services.

The board recommended a final dividend of 0.0595 yuan per share and a special dividend of 0.1352 yuan for the year, payable Sept. 2 to shareholders of record on Aug. 13, subject to shareholders approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment